Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Business Ethics & Compliance

Transparency in healthcare

We are firmly focused on our mission and take our responsibility very seriously regarding the need for a transparent way of acting.
As a member of international industry associations, accordingly to national/regional laws, regulations and industry code requirements on transparency, Menarini discloses transfer of value to HealthCare Professionals, HealthCare Organizations and Patient Organizations.

Disclosure Reports

Patient Experts disclosure

Menarini is committed to an open dialogue and a transparent exchange of information with patient organizations since we believe that listening to and understanding the patient represents a fundamental element of knowledge for an effective value proposition within the Healthcare System, resulting in an improvement in the clinical outcome of patients.
We are strongly convinced that health and well-being must be a fundamental right for every patient or rather for every person, as stated in article 25 of the Universal Declaration of Human Rights. For this reason, we work every day to ensure that more patients can sustainably access the care they need in the therapeutic areas relevant to our products.
To this end, our engagement with the world of patients is driven by a desire to understand and address gaps in access to care, to provide concrete solutions to fill them and to ensure better access to our medicines.
Increasing the contact surface and active listening with the world of patients represents an enrichment at all levels of the Company. This leads to a deep understanding of patients’ needs, difficulties and expectations when it comes to deal with diseases and treatments, as well as a decisive step in the direction of sustainable healthcare.